← The Wire
FLNANasdaq
FILANA THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 1069530
Develops transformative medicines for CNS disorders by modulating filamin A, with simufilam for TSC-related epilepsy
red 8-K · 90d
$60M
Market cap
$1.22
Last close
+1.7%
1D
-1.6%
5D
216K
Volume
Price · last 39 sessions-12.9%
May 4L $1.16 · H $1.55Jun 29
362
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 15, 202610-QFORM 10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEF 14AFORM DEF 14AApr 28, 20268-KExecutive ChangeApr 28, 202610-KFORM 10-KMar 12, 20268-KResults of OperationsMar 12, 20268-KBylaw Amendment · Reg FD DisclosureMar 10, 20268-KReg FD Disclosure · Company UpdateFeb 19, 20268-KMaterial AgreementDec 23, 20258-K/AExecutive ChangeDec 22, 20258-KCompany UpdateDec 18, 20258-KExecutive ChangeDec 17, 20258-KCompany UpdateDec 3, 202510-QFORM 10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KCompany UpdateOct 24, 20258-KExecutive Change · Reg FD DisclosureOct 22, 20258-KReg FD DisclosureSep 8, 202510-QFORM 10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KReg FD Disclosure · Company UpdateAug 4, 20258-KReg FD DisclosureJun 30, 20258-KExecutive Change · Shareholder VoteMay 27, 202510-QFORM 10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KExecutive Change · Reg FD DisclosureApr 21, 2025DEF 14AFORM DEF 14AApr 14, 20258-KReg FD Disclosure · Company UpdateMar 25, 20258-KExecutive ChangeMar 11, 202510-KFORM 10-KMar 3, 20258-KResults of OperationsMar 3, 20258-KMaterial Agreement · Reg FD DisclosureFeb 27, 20258-KResults of Operations · Exit / Disposal CostsJan 7, 20258-KCompany UpdateNov 25, 202410-QFORM 10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KReg FD DisclosureOct 8, 20248-K/AExecutive ChangeOct 1, 20248-KReg FD Disclosure · Company UpdateSep 27, 20248-KCompany UpdateSep 17, 20248-KExecutive Change · Reg FD DisclosureSep 9, 20248-K/AResults of OperationsAug 9, 202410-QFORM 10-QAug 8, 20248-KDelisting Notice · Results of OperationsAug 8, 20248-KReg FD DisclosureJul 22, 20248-KCompany UpdateJul 18, 20248-KExecutive Change · Reg FD DisclosureJul 17, 20248-KCompany UpdateJul 1, 20248-KExecutive ChangeMay 22, 20248-KShareholder VoteMay 13, 202410-QFORM 10-QMay 10, 20248-KResults of OperationsMay 10, 20248-KCompany UpdateMay 8, 20248-KCompany UpdateMay 1, 20248-KCompany UpdateApr 15, 2024DEF 14AFORM DEF 14AMar 26, 202410-KFORM 10-KFeb 28, 20248-KResults of OperationsFeb 28, 20248-KCompany UpdateFeb 7, 20248-KMaterial AgreementJan 3, 20248-KReg FD Disclosure · Company UpdateDec 12, 20238-KExecutive Change · Reg FD DisclosureDec 11, 202310-QFORM 10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KBylaw AmendmentSep 13, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KCompany UpdateJul 5, 20238-KShareholder VoteMay 8, 20238-KMaterial Agreement · Agreement TerminatedMay 1, 2023424B5424B5May 1, 202310-Q10-QMay 1, 20238-KResults of OperationsMay 1, 2023DEF 14ADEF 14AMar 27, 20238-KExecutive ChangeMar 17, 20238-KCompany UpdateMar 10, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 28, 20238-KCompany UpdateJan 24, 2023
Insider Activity
◆ Cluster Buy · 3 insidersIn the 90 days to Nov 24, 2025: 3 insiders bought $681K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 24, 2025 | Anderson Robert Eugene JrDirector | Buy | 8,600 | $2.90 | $25K |
| Nov 20, 2025 | Barry RichardPresident & CEO | Buy | 150,000 | $2.76 | $414K |
| Nov 19, 2025 | Barry RichardPresident & CEO | Buy | 73,385 | $2.75 | $202K |
| Sep 30, 2025 | Cook Robert ChristopherChief Operating & Legal Office | Buy | 13,725 | $2.91 | $40K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance